Recent submissions

Comment · 4 years ago
This is a point you can make, but it's distinct from sovereignty being infringed. If Parliament is sovereign, it can decide to give away powers, no?
Comment · 4 years ago
The UK Parliament ratified the Treaty? How is its sovereignty violated by something it itself agreed to?
Comment · 4 years ago
This is the dilemma in a nutshell. There are lots of incredibly smart people working in the web3 space who are aware of its limitations, but for every one of those, there are 1000 people just trying to make as much money as possible.
Comment · 4 years ago
Comment · 5 years ago
Comment · 5 years ago
Munich does have Infineon as well and it's closer to lots of the eventual customers in the automobile industry.
Comment · 5 years ago
Comment · 5 years ago
Good point, however the more important question is what is meant by "careful".
Comment · 5 years ago
The precise question was:

"Would you say that you are free to express your opinion in public or do you have to be careful with certain or many topics?" („Würden Sie sagen, man kann seine Meinung in der Öffentlichkeit frei äußern oder muss man bei einigen oder vielen Themen vorsichtig sein?“)

As a German, I believe that I am free to express my opinion, nevertheless I would say that there are obviously many topics of discussion where one has to be careful just because there is lots of potential to be misunderstood.

How am I supposed to answer this poll?

Comment · 5 years ago
https://blogs.sciencemag.org/pipeline/archives/2021/02/02/my...

This is about mRNA vaccines, but similar things exist for viral vector vaccines as well. Technology transfer, bioreactor bags, fill-finish capacity, all of these things are bottlenecked till next year basically.

Comment · 5 years ago
They rightly fear that in 2-3 years, when the pandemic is likely over everywhere and other people have figured out how to commercialize the IP, they won't be the only ones producing their vaccines.

This isn't going to help India or anyone in the short term and there'll be more than enough doses for every person on Earth by next year. Why should they not retain the IP rights to make a profit on new generations that need to be vaccinated or potential booster shots? The manufacturing capacity will have been built up so scarcity won't be a problem at that point.

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton